Results 171 to 180 of about 7,678,480 (399)

Health trend survey: Consumers like Internet, alternative medicine; employers lukewarm on quality measurement [PDF]

, 1999
Deborah Christie-Smith
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Growing popularity of alternative medicine documented in new survey [PDF]

, 1999

openalex   +1 more source

First national survey of anthroposophic nurses in NZ [PDF]

, 2018
Anthroposophic health care although listed as a Complementary and Alternative Medicine (CAM) – approach according to the Ministerial Advisory Committee for Complementary and Alternative Health (MACCAH, 2002;2004) in New Zealand (NZ), is an integrated ...
Te Huia, Maria
core  

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

*Burket's oral medicine: diagnosis and treatment / Management of war injuries to the jaws and related structures / Alternatives to gold alloys in dentistry / Introduction to periodontics / A century of dentistry: a history of the University of Pennsylvania School of Dental Medicine 1878-1978 / Epidemiology, etiology, and prevention of periodontal diseases / Annotations / Additions to the Library*Titles preceded by an asterisk are available from the ADA library

, 1979
Edward A. Woods, Bob D. Gross, Jacob A. Salzman, Saul Schluger, Donald A. Washburn, Paul N. Baer   +5 more
openalex   +1 more source

Alternative therapies and complementry medicine: A mutiny in the making [PDF]

, 1998
Harry D. Friedman
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Gardenia jasminoides extract mitigates acetaminophen-induced liver damage in mice

BMC Complementary Medicine and Therapies
Background Acetaminophen (APAP)-induced hepatotoxicity is a potentially life-threatening condition. Gardenia jasminoides fruit extract (GJE), which contains geniposide (Gen) as its major active constituent, possesses anti-inflammatory and antioxidant ...
Peenaprapa Tangpradubkiat, Maneerat Chayanupatkul, Pornpen Werawatganone, Kanjana Somanawat, Prasong Siriviriyakul, Naruemon Klaikeaw, Duangporn Werawatganon   +6 more
doaj   +1 more source